Menu
Recruiting NCT07276295

Synthetic Versus Autologous Sling For Stress Incontinence

No phase Interventional Urinary Incontinence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: autologous fascia sling, tension-free vaginal tape.
Who it may be relevant to
Registry conditions: Urinary Incontinence. Basic parameters: from 60 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Synthetic Versus Autologous Sling For Stress Incontinence (SASSI): A Randomized Controlled Trial

Overview

This is a multi-centre randomized controlled trial comparing mid-urethral synthetic mesh sling or tension-free vaginal tape (TVT) and autologous fascia sling (AFS) in elderly patients with stress predominant urinary incontinence. The investigators aim to investigate new onset pelvic pain 6 months post-op and objective urinary incontinence cure rate 5 years post-op. Secondary objectives include investigation of opioid use, mental health, sexual health, and other post-op outcomes.

Interventions

  • Procedure autologous fascia sling
    Participants will receive autologous fascia sling as surgery for stress predominant urinary incontinence.
  • Procedure tension-free vaginal tape
    Participants will receive tension-free vaginal tape as surgery for stress predominant urinary incontinence.

Primary outcome measures

  • Objective urinary incontinence status measured by standing cough test [Time frame: 5 years post-op]
  • Incidence of new-onset chronic abdominopelvic pain since surgery by Likert pain intensity scale [Time frame: 6 months post-op]

Eligibility criteria

Inclusion criteria

  • Adult females at birth (female anatomy, any gender)
  • Greater than or equal to 60 years old
  • Have stress predominant urinary incontinence (spUI) eligible for both types of surgery (tension-free vaginal tape and autologous fascia sling)
  • Exhausted conservative management options for UI (Kegel's exercises, physiotherapy, pessary)
  • Completed childbearing
  • Able to follow up with clinic visits for up to five years after surgery

Exclusion criteria

  • Clinical Frailty Score of 6 or more, as moderate frailty is likely associated with excessive postoperative deterioration
  • Concurrent pelvic surgery
  • Neurogenic bladder
  • Previous UI surgery
  • Previous pelvic radiation
  • Previous mesh exposure
  • Presence of pelvic pain for more than three months in the last five years
  • Likely unable to follow up
  • Immunocompromised individuals receiving immunosuppressive medications for at least 3 months
  • Chronic systemic steroid use for at least 3 months for autoimmune diseases
  • Unable to stop smoking for at least 3 months prior to surgery and at high risk of restart smoking post-operatively

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Canada · 1 center
  • St. Paul's Hospital — Vancouver

Identifiers

NCT: NCT07276295 · H25-02899

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗